Matthew Hewitt, B.A. Ph.D., currently serves as Vice President, Chief Technical Officer for the Manufacturing Business Division at Charles River Laboratories (CRL) playing a critical role in driving the technical and strategic vision for CRL’s CDMO, Testing, and Microbial Solutions global business line.

Before joining CRL, he was Head of R&D and Clinical Development for Lonza’s Personalized Medicine Business Unit where he led the development of Cocoon, a closed, automated, scalable cell therapy manufacturing solution. In this capacity, he executed numerous collaborations across academia and industry leveraging the Cocoon. Prior to Lonza, Matt led the Tumor Immunology and Microenvironment program at Bellicum Pharmaceuticals, focusing on improving cell therapy efficacy in solid tumors. He also led the Immunology group at the University of Pennsylvania’s Gene Therapy Program, leading and contributing to numerous AAV gene therapy programs.